"The U.S. Food and Drug Administration today approved the MemoryShape Breast Implant to increase breast size (augmentation) for use in women at least 22 years old and to rebuild breast tissue (reconstruction) in women of any age. The MemoryShape B"...
The use of FEIBA VH (AICC) is contraindicated in patients who are known to have a normal coagulation mechanism.This monograph has been modified to include the generic and brand name in many instances.
Last reviewed on RxList: 10/7/2008
Additional Feiba Vh Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find out what women really need.